“A means of granting controlled access to drugs in response to requests by health professionals on behalf of specific, or “named”, patients before those medicines are licensed.
The patients must have exhausted all alternative treatment options and not match clinical trial entry criteria.
Often called compassionate use, expanded access, or named patient supply.”